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Objectives. This study sought to compare acute lumen changes 
and late lumen narrowing during and after excimer laser.assisted 
balloon angioplasty, measured by quantitative coronary angiog- 
raphy, with the immediate and long-term outcome of balloon 
angioplasty alone. 
Background. Although excimer laser coronary angioplasty is 
used as an adjunct or alternative to balloon angioplasty, limited 
comparative data exist regarding the immediate and long-term 
efficacy of excimer laser-assisted balloon angioplasty versus bal- 
loon angioplasty alone. 
Methods. A series of 53 lesions in 47 consecutive patients 
successfully treated with excimer laser-assisted balloon angio- 
plasty were individually matched after completion of 6-month 
follow-up angiography with 53 successfully treated balloon angio- 
plasty lesions according to vessel ocation, preprocedural minimal 
lumen diameter and reference diameter. Immediate and long- 
term angiographic results were assessed by an automated lumen 
contour detection algorithm. 
Results. Before intervention in the laser and balloon angio- 
plasty groups, respectively, minimal lumen diameter (mean - 
SD) was 0.73 _+ 0.47 and 0.74 -+ 0.46 ram, and reference diameter 
was 2.71 -+ 0.42 and 2.72 + 0.41 mm. Laser angioplasty was 
followed by adjunctive balloon dilation in 50 lesions. Mean 
balloon diameter at maximal inflation was similar in both treat- 
ment groups (2.61 "4- 0.32 and 2.65 - 0.38 mm, respectively), 
resulting in similar minimal lumen diameters after intervention 
of 1.77 -+ 0.41 and 1.78 + 0.34 mm, respectively. At follow-up 
angiography, minimal lumen diameter after excimer laser- 
assisted balloon angioplasty was 1.17 _+ 0.63 mm, and that after 
balloon angioplasty alone was 1.46 -+ 0.67 mm (p = 0.02). The 
angiographic restenosis rates at follow-up using the 50% diameter 
stenosis cutoff criterion were 57% and 34%, respectively (p = 0.02). 
Conclusions. Quantitative angiographic analysis of a matched 
group of 106 successfully treated coronary lesions showed a 
similar immediate outcome but reduced long-term efficacy of 
excimer laser-assisted balloon angioplasty compared with that 
after balloon angioplasty alone. 
(J Am Coil Cardiol 1995;26:939-46) 
Currently, transluminal balloon angioplas~ (1) remains the 
most common applied technique for the percutaneous treat- 
ment of patients with coronary artery disease. In an attempt to 
improve primary success and to reduce acute complication and 
long-term restenosis rates associated with balloon coronary 
angioplasty, a variety of novel techniques and devices have 
been introduced over the past 10 years (2,3). Excimer laser 
coronary angioplasty removes atherosclerotic plaque by laser 
ablation, that is, vaporization of plaque tissue by short pulses 
of excimer laser radiation delivered through a fiberoptic ath- 
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eter (4,5). Since the first patient with coronary artery disease 
was treated with a xenon chloride xcimer laser in August 1988 
(6), excimer laser angioplasty has been increasingly used as an 
adjunct or alternative to balloon angioplasty (7-11). Although 
laser angioplasty is followed by balloon dilation in more than 
90% of cases ("to debulk and dilate"), it is hypothesized that 
reduction of atherosclerotic tissue mass by laser ablation with 
or without adjunctive balloon dilation may be more effective in 
enlarging the vessel umen than balloon angioplasty alone. 
Data on thousands of patients undergoing excimer laser coro- 
nary angioplasty have now been accumulated in prospective, 
observational registries (10,11). The reported primary success 
and complication rates of excimer laser angioplasty with or 
without adjunctive balloon dilation compared favorably with 
those of balloon angioplasty alone, specifically in complex 
coronary artery lesions (8-14). However, comparative data on 
the immediate and long-term efficacy of excimer laser versus 
balloon coronary angioplasty are limited (8,10), and a reliable 
assessment of long-term results of excimer laser angioplasty is 
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hampered by low angiographic follow-up rates in most pub- 
lished reports. 
The aim of the present study was to compare the immediate 
and long-term efficacy of excimer laser versus balloon c ronary 
angioplasty in matched patient groups with similar baseline 
stenosis characteristics and anginal patterns and complete late 
angiographic follow-up. In the past, this comparative approach 
of lesion matching has been satisfactorily applied by our group 
to compare the short- and long-term outcomes of directional 
atherectomy and balloon angioplasty (15) as well as stent 
implantation and balloon angioplasty as a surrogate for ran- 
domized trials (16). Indeed, these matching studies have 
accurately predicted the angiographic outcomes of recently 
completed randomized investigations (17-20) comparing these 
new interventional techniques with conventional balloon cor- 
onary angioplasty. 
Methods 
Patients. For the purpose of the present study, a consecu- 
tive series of patients with native coronary artery lesions 
successfully treated by excimer laser-assisted balloon angio- 
plasty was prospectively included. All patients had symptom- 
atic coronary artery disease or objective evidence of myocar- 
dial ischemia, or both. A successful treatment was defined as 
procedural success (<50% residual diameter stenosis at the 
end of the intervention) without death, nonfatal myocardial 
infarction, bypass graft surgery or repeat angioplasty during 
the hospital period. Within the time frame of this study, 50 
patients completed a 6-month follow-up period after a success- 
ful procedure for 56 coronary artery lesions. This patient 
cohort represents almost a fourth of the population treated 
with the excimer laser atour institution until now and reflects 
our experience with the device after completion of a learning 
curve. All patients except one (98% of eligible patients) 
underwent actual follow-up angiography n average (+SD) of 
5.7 (_+ 1.5) months after intervention. Two patients successfully 
treated with excimer laser angioplasty for a chronic total 
coronary occlusion could not be satisfactorily matched with 
patients treated by balloon angioplasty according to the anglo- 
graphic criteria described later. Th  study group, therefore, 
included 47 patients with 53 coronary artery lesions success- 
fully treated by excimer laser-assisted balloon angioplasty who 
were individually matched with patients who had undergone 
successful conventional balloon c ronary angioplasty. The 
clinical and angiographic details of the two treatment groups 
are described in Table 1. 
Laser procedure. The laser system consisted of a xenon 
chloride excimer laser (Advanced I terventional Systems, Inc.) 
emitting light pulses at a wavelength of 308 nm with a pulse 
duration of -200 ns and a repetition rate of 20 to 30 Hz. Over 
the wire laser catheters of 1.3-, 1.6-, and 2.0-mm diameter with 
a concentric multifiber arrangement around a central guide 
wire lumen were used. Laser ftuence at the catheter tip was set 
at levels ranging from 45 to 65 mJ/mm 2. For anticoagulation, 
aspirin and hcparin were given intravenously with additional 
Table 1. Baseline Characteristics of Matched Patients and Lesions 
Before Excimer Laser Coronary Angioplasty and Balloon 
Coronary Angioplasty 
ELCA PTCA 
(n = 47) (n = 53) 
Age (yr) 55.8 _+ 9.2 57.4 -- 8.6 
Male gender (%) 77 79 
Angina class (CCS) (%) 
I 2 2 
II 26 32 
II1 57 53 
IV 15 13 
Lesions (no.) 53 53 
Location (no.) 
LAD 27 27 
RCA 17 17 
LCx 9 9 
Total occlusions (no.) 12 12 
Minimal lumen diameter (ram) 0.73 -- 0.47 0.74 _+ 0.46 
Reference diameter (mm) 2.71 _+ 0.42 2.72 _+ 0.41 
Diameter stenosis (%) 73 _+ 17 73 _+ 17 
Minimal lumen cross-sectional area (mm 2) 0.59 _+ 0.50 0.60 _ 0.49 
Reference area (ram 2) 5.92 _+ 1.83 5.95 _+ 1.83 
Area stenosis (%) 90 _+ 9 90 _+ 9 
Lesion length (mm)* 8.1 +_ 3.6 6.6 _+ 3.1 
Plaque area (ram2) * 10.1 _+ 4.9 8.0 _+ 6.0 
*For nontotal obstructions only (n = 41 in both groups), p = NS for all 
variables. Data presented are mean value _+ SD or number or percent of patients 
or lesions. CCS = Canadian Cardiovascular Society; ELCA = excimer laser 
coronary angioplasty; LAD = left anterior descending coronary artery; LCx = 
left circumflex coronary artery; PTCA = balloon coronary angioplasty; RCA = 
right coronary artery. 
doses of heparin as required to keep the activated clotting time 
>400 sfor the duration of the procedure. The laser angioplasty 
procedure as performed in our institution has been described 
in detail previously (21). If, after one pass with the laser 
catheter, the residual diameter stenosis was >50%, the l sion 
was passed with a larger diameter laser catheter, or adjunctive 
balloon dilation was performed. In three patients with three 
lesions, stand-alone laser angioplasty resulted in a satisfactory 
angiographic result. Before and after the laser procedure (and 
adjunctive balloon dilation), angiography was performed in 
multiple projections after intracoronary administration f ni- 
troglycerin to control vasomotor tone. After intervention, the 
patients were monitored for 24 h, and 12-lead electrocardio- 
grams were corded and cardiac enzyme levels were measured 
twice a day. Six hours after the procedure, the sheaths were
removed. After recanalization of a total or subtotal occlusion, 
a heparin infusion was maintained until the next morning; 
then, heparin was discontinued, and the sheaths removed. The 
only specific postprocedural drug e imen consisted of aspirin 
for 6 months. The patients were evaluated at the outpatient 
clinic at 1 and 6 months after the procedure or earlier if 
dictated by recurrence of symptoms. Late follow-up angiogra- 
phy was performed after intracoronary administration f ni- 
troglycerin, replicating exactly the projections and settings 
used during the intervention. 
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Quantitative coronary angiography. For each treated seg- 
ment, the minimal umen and reference diameters b fore and 
after the procedure and at follow-up angiography were derived 
from multiple matched projections. All cineangiograms were 
analyzed using the computer-based Cardiovascular Angiogra- 
phy Analysis System (CAAS), which asbeen described and 
validated previously (22-25). This system permits an objective 
and reproducible quantification of the minimal umen diame- 
ter of a coronary segment in absolute millimeters. A computer- 
derived estimation ofthe original arterial dimension at the site 
of obstruction (assuming there is no disease present) is used to 
define the interpolated reference diameter. The percent diam- 
eter and area stenosis as well as the cross-sectional rea (in 
ram2), are then calculated. The length of the lesion (in mm) is 
determined from the diameter function on the basis of a 
curvature analysis. The area between the actual and recon- 
structed contours at the obstruction site s a measure of the 
amount of atherosclerotic plaque and is expressed in mm 2. 
Because the algorithm cannot measure total occlusions, a value 
of 0 mm was imputed for the minimal umen diameter and a 
value of 100% for percent diameter stenosis. In these cases, the 
reference diameter after intervention was substituted for the 
reference diameter before intervention rat follow-up, respec- 
tively. To obtain the mean balloon diameter, the largest 
balloon at maximal inflation was measured in a nonforeshort- 
ened projection. 
Matching process. To compare coronary lumen changes 
occurring during and after excimer laser-assisted balloon an- 
gioplasty with the short- and long-term changes during and 
after balloon angioplasty alone, a consecutive series of 53 
lesions successfully treated by excimer laser (+balloon) angio- 
plasty were matched with 53 successfully treated balloon 
angioplasty lesions. The coronary artery tree was subdivided 
into 15 segments according to the American Heart Association 
guidelines, and the lesions were individually matched accord- 
ing to preprocedural minimal umen diameter, eference di- 
ameter and vessel location. The principles of matching by 
quantitative angiography arc as follows (15,16,26): 1) The
angiographic dimensions of matched lesions are assumed to be 
identical; and 2) the observed difference in minimal lu en and 
reference diameters b tween the two identical lesions must be 
within the range of reproducibility of the quantitative analysis 
system for lesion measurement (1 SD = 0.10 mm) (22-25). 
Thus, lesion pairs were selected in which the difference be- 
tween these angiographic variables did not exceed 0.2 mm 
(twice the variability, 95% confidence limits). After completion 
of matching for these three angiographic variables, thepa- 
tients' anginal status was introduced as an additional, clinical 
characteristic toenhance and refine th  matching process. The 
data base from which the balloon angioplasty lesions were 
selected contains quantitative angiographic data on 3,736 
coronary lesions treated by balloon angioplasty, enabling sat- 
isfactory matching of lesions and patients undergoing different 
interventions. Matching was performed by an independent 
unbiased physician (R.M.) without knowledge of procedural or 
clinical outcomes according to the aforementioned criteria. 
Assessment of restenosis. The following criteria were used 
to asses the long-term etficacy of excimer laser and balloon 
coronary angioplasty: 1) The primary angiographic variable of 
interest in this study representing the final angiographic out- 
come of either intervention was the minimal umen diameter at 
follow-up. 2) The second criterion for restenosis chosen was 
->50% diameter stenosis at follow-up, derived from the mini- 
mal lumen diameter and reference diameter of the vessel. This 
restenosis rate according to the categoric (dichotomous) ap- 
proach was used because in clinical practice decision maki g is 
still based on this cutoff criterion, and it is the conventionally 
recognized angiographic definition of restenosis. 3) The third 
variable uses the gain in minimal lumen diameter achieved 
during an intervention and the subsequent lumen loss during 
follow-up related to the vessel size (reference diameter), 
enabling a comparison among vessels of different caliber (26). 
The relative gain is calculated as (Postintervention minimal 
lumen diameter - Preintervention minimal lumen diameter)/ 
Reference diameter, and relative loss as (Postintervention 
minimal lumen diameter - Follow-up minimal lumen 
diameter)/Reference diameter. The relation between relative 
gain and relative loss was studied by means of regression 
analysis because there is experimental nd clinical evidence of 
a proportional relation between the xtentof vessel wall injury 
inflicted by an intervention (reflected angiographically as lu- 
men gain) and the subsequent reparative response, that is
intimal hyperplasia (reflected angiographically aslumen loss) 
(15,16,26-32). 4) The net gain in lumen improvement at 
follow-up normalized for vessel size is described by the net gain 
index: (Follow-up minimal lumen diameter - Preintervention 
minimal lumen diameter)/Reference diameter. 5) The loss 
index, as proposed by Kuntz et al. (33) and defined aslate loss 
divided by acute gain, was calculated as (Postintervention mini- 
mal lumen diameter - Follow-up minimal lumen diameter)/ 
(Postintervention minimal umen diameter - Preintervention 
minimal umen diameter). 
Statistical analysis. All values obtained from quantitative 
angiographic analysis and derived variables are expressed as 
mean value +_ SD. Differences between the two groups and 
within each group were assessed by two-factor repeated- 
measures analysis of variance. The Bonferroni correction was 
applied for multiple comparisons. Simple regression analysis 
was used to evaluate the relative gain/relative loss relation in 
each group. To compare the linear regressions for the two 
treatment groups, multiple regression analysis was performed 
introducing the type of intervention as a dummy variable. A p 
value <0.05 was considered to indicate a significant difference. 
Results 
Matching. Baseline clinical nd quantitative angiographic 
characteristics of the two matched patient groups are pre- 
sented in Table 1. No significant differences in ge der, age or 
anginal status were observed. Matching for angiographic vari- 
ables was satisfactory with identical distribution f stenosis 
location and similar minimal lumen diameter and reference 
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Figure 1. Cumulative frequency curves to illustrate the immediate 
(top) and long-term (bottom) changes in minimal lumen diameter 
(MLD) induced by excimer laser-assisted balloon angioplasty (ELCA) 
and balloon angioplasty alone (PTCA) as assessed by quantitative 
coronary angiography. FUP = at follow-up; PRE (POST) = before 
(after) intervention. 
diameter measurements in both groups: 0.73 ± 0.47 and 2.71 ___ 
0.42 mm for the laser angioplasty group and 0.74 z 0.46 and 
2.72 +_ 0.41 mm for the balloon angioplasty group, respectively. 
The cumulative distribution curves for the minimal lumen 
diameter before either intervention (Fig. 1) can be seen to 
overlap suitably. Other lesion variables (diameter stenosis, 
minimal lumen cross-sectional rea, reference area, area ste- 
nosis, lesion length and plaque area) also did not differ 
significantly between groups. Qualitative descriptors f lesion 
morphology derived from visual analysis of coronary anglo- 
grams included the presence of a branch point in the stenotic 
segment (47% in the laser group vs. 49% in the balloon group), 
lesion calcification (23% vs. 13%, respectively) and relation of 
the lesion to a coronary bend (11% vs, 8%, respectively), which 
were not significantly different between groups. In both groups, 
12 total occlusions were present before intervention (23% of 
total group). Thus, this matching technique resulted in the 
selection of two patient groups with similar clinical and 
preprocedural stenosis variables. 
Immediate results. The immediate outcome after excimer 
laser-assisted balloon angioplasty and balloon angioplasty 
alone as assessed by quantitative coronary angiography is 
shown in Figure 1 (top) and Tables 2 and 3. The reference 
Table 2. Comparative Quantitative Angiographic Analysis of 
Immediate and Follow-Up Results of Excimer Laser (---Balloon) 
Angioplasty and Balloon Angioplasty Alone in 53 Coronary Lesions 
ELCA PTCA 
(mean _+ SD) (mean ± SD) 
Minimal lumen diameter (mm) 
Pre 0.73 ± 0.47 0.74 _+ 0.46 
Post 1.77 + 0.41 1.78 _+ 0.34* 
F-up 1.17 ± 0.63 1.46 +_ 0.67t 
Reference diameter (ram) 
Pre 2.71 ± 0.42 2.72 _+ 0.41 
Post 2.84 ___ 0.49 2.69 --0.44 
F-up 2.75 _~ 0.57 2.78 ±0.56 
Diameter stenosis (%) 
Pre 73 ~ 17 73 ± 17 
Post 37 -+ 11 34 -+ 10' 
F-up 57 -+ 21 47 _+ 24t 
Minimal lumen cross- 
sectional area (ram 2) 
Pre 0.59 ± 0.50 0.60 ± 0.49 
Post 2.60 ± 1.26 2.57 ± 1.05" 
F-up 1.37 ± 1.15 2.02 _+ 1.36t 
Reference area (ram 2) 
Pre 5.92 + 1.83 5.95 ÷ 1.83 
Post 6.49 ± 2.32 5.84 -- 1.99 
F-up 6.17 ± 2.70 6.29 _+ 2.68 
Area stenosis (%) 
Pre 90 _+ 9 90 _+ 9 
Post 60 +_ 13 55 _+ 13' 
F-up 77 +_ 15 66 _+ 20i" 
*p < 0.01 within groups, ?p< 0.05 interaction. F-up = at follow-up; Post = 
after intervention; Pre = before intervention; other abbreviations as in Table 1, 
diameter did not change significantly after either intervention 
(from 2.71 ___ 0.42 to 2.84 _+ 0.49 mm in the laser angioplasty 
group vs. 2,72 +__ 0.41 to 2.69 ± 0.44 mm in the balloon 
angioplasty group). Both procedures resulted in a significant 
improvement in minimal umen diameter; postprocedural min- 
imal lumen diameter was 1.77 _ 0.41 mm in the laser group 
and 1.78 +_ 0.34 mm in the balloon-only group. Percent 
diameter stenosis after intervention was not different between 
groups (37 -+ 11% vs. 34 + 10%, respectively). Excirner laser 
angioplasty alone resulted in significant lesion debulking (min- 
imal lumen diameter from 0,73 _+ 0.47 to 1.30 _+ 0.29 mm [p < 
0.001]; 55% of acute gain in minimal lumen diameter in 
Table 3. Procedural Variables Derived From Quantitative 
Coronary Angiography 
ELCA PTCA p 
(mean ± SD) (mean _+ SD) Value 
Mt,D after ELCA alone (ram) 1.30 ± 0.29 - -  - -  
Balloon size (ram) 2.61 ± 0.32 2.65 ± 0.38 0.34 
(n 50) (n =53) 
MLD after intervention (ram) 1.77 ± {).41 1.78 +_ 0.34 0.97 
,Absolute gain (ram) 1.04 -+ 054 1.03 ___ 0.57 0.96 
Relative gain 0.39 ± 0.21 0.38 ± 0.2l 0.88 
MLD = minimal lumen diameter: other abbreviations as in Table1. 
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Table 4. Follow-Up Variables Derived From Quantitative 
Coronary Angiography 
ELCA PTCA p 
(mean _+ SD) (mean _+ SD) Value 
MLD at follow-up (ram) 1.17 _+_ 0.63 1.46 _+ 0.67 0.02 
DS -> 50% at follow-up (%) 57 34 0.02 
Absolute loss (mm) 0.60 ___ 0.63 0.31 _+ 0.64 0.02 
Relative loss 0.23 _+ 0.25 0.12 _+ 0.24 0.01 
Net gain index 0.16 _+ 0.21 0.27 _+ 0.27 0.02 
Loss index 0.63 _+ 0.77 0.35 _+ 1.01 0.10 
DS = diameter stenosis: other abbreviations as in Tables 1 and 3. 
the laser group). However, after adjunctive balloon dilation in 
50 (94%) of 53 lesions, total acute gain in minimal umen 
diameter after laser-assisted balloon angioplasty was similar to 
that after balloon angioplasty alone (1.04 _ 0.54 vs. 1.03 _+ 
0.57 ram, respectively). Balloon diameter at maximal inflation 
was similar in both groups (2.61 _+ 0.32 and 2.65 __ 0.38 mm, 
respectively). Because of this nearly identical immediate out- 
come, any differences in late outcome may be attributable to 
the type of treatment received (laser angioplasty or balloon 
dilation). 
Figure 2. Scattergram of values obtained for relative gain in thegroup 
undergoing coronary excimer laser-assisted balloon angioplasty 
(ELCA) (top) or balloon angioplasty alone (PTCA) (bottom) and 
relative loss during the follow-up eriod. A linear relation emerges for 
both techniques; however, a steeper slope of the regression line is 
found in the excimer laser-assisted balloon angioplasty group (0.71 vs. 
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Long-term results. Quantitative angiographic results at 
follow-up are summarized in Figure 1 (bottom) and Tables 2 
and 4. The minimal lumen diameter at follow-up was signifi- 
cantly smaller after excimer laser-assisted balloon angioplasty 
than after balloon angioplasty alone (1.17 + 0.63 vs. 1.46 _+ 
0.67 mm, respectively, p = 0.02), with consequently higher 
percent diameter stenosis (57 + 21% vs. 47 + 24%, respec- 
tively, p = 0.02) and lower net gain index (0.16 _+ 0.21 vs. 
0.27 + 0.27, respectively, p = 0.02). Although relative lumen 
gain was equal in both treatment groups, relative lumen loss in 
the laser angioplasty group was almost wice as much as in the 
balloon angioplasty group (0.23 + 0.25 vs. 0.12 _+ 0.24, 
respectively, p = 0.01). Simple regression analysis demon- 
strated a linear relation between relative gain and relative loss 
for each treatment group (Fig. 2), although the coefficient of 
correlation was comparatively low in both groups. The slope of 
the regression line was steeper in the excimer laser group 
(0.71) than in the balloon angioplasty group (0.30); this 
difference was of borderline statistical significance (p = 0.05). 
Loss index was greater in the laser angioplasty group than in 
the balloon angioplasty group (0.63 + 0.77 vs. 0.35 _+ 1.01, 
respectively), although this difference did not reach statistical 
significance (p = 0.10). According to the categoric approach, 
using the conventional 50% diameter stenosis cutoff criterion, 
the angiographic restenosis rate at follow-up was 57% after 
excimer laser-assisted balloon angioplasty and 34% after bal- 
loon angioplasty alone (p = 0.02). 
Discuss ion  
Matching studies. With the introduction of excimer laser 
angioplasty for the treatment of coronary artery disease (4- 
11), it was hoped that, besides improvement of acute success 
and complication rates (8-14), the incidence of restenosis with 
this new intervention would be reduced in comparison with 
conventional balloon angioplasty. So far, direct comparisons of
excimer laser versus balloon coronary angioplasty in the treat- 
ment of lesions with similar angiographic morphology are few 
(34). Before the results of prospective, randomized trials 
became available, the comparative evaluation of matched 
coronary lesions undergoing different interventions was recog- 
nized as a valid method of comparing the short- and long-term 
efficacy of a new technique relative to conventional balloon 
angioplasty (15,16,26,35). In fact, the comparative quantitative 
angiographic analysis of matched lesions undergoing different 
interventions has accurately predicted the angiographic out- 
comes of subsequent randomized investigations of directional 
atherectomy (15,17,18) and coronary stenting (16,19,20) versus 
balloon angioplasty. Applying the same methodology of lesion 
matching presented an excellent opportunity o investigate the 
immediate and long-term results of excimer laser angioplasty 
compared with conventional balloon coronary angioplasty. 
Immediate results. The immediate angiographic outcome 
of excimer laser-assisted balloon angioplasty was similar to that 
of conventional balloon angioplasty despite significant lesion 
debulking by excimer laser ablation, which accounted for 55% 
944 STRIKWERDA ET AL. JACC Vol. 26, No. 4 
OUTCOMES OF LASER AND BALLOON ANGIOPLASTY October 1995:939-46 
of the total gain in minimal lumen diameter in the laser-treated 
group. We recently demonstrated (21) that elastic recoil of the 
vessel wall after excimer laser-assisted balloon angioplasty is
similar to that after balloon angioplasty alone using balloon 
catheters of equal size. The present findings may point toward, 
at least in part, a dilatory ("Dotter") effect of excimer laser 
angioplasty rather than effective debulking of plaque tissue as 
in directional atherectomy (15,21,26,36). Coaxial de ivery of 
excimer laser pulses in arteries is accompanied by the genera- 
tion of shock waves (37) and the repetitive formation and 
collapse of vapor bubbles causing explosive dilation and invag- 
ination of the adjacent arterial segment (38,39). Examination 
by intravascular angioscopy of the morphologic hanges in- 
duced by pulsed excimer laser angioplasty in peripheral and 
coronary arteries (40) has revealed issection flaps, fractures 
of plaques and abundant tissue remnants that corresponded to
angiographic findings of haziness and dissections. Channels 
recanalized by multifiber laser catheters that emitted fluences 
of 40 to 60 m J/ram 2 were small and irregular, indicating 
insufficient tissue removal. In a recent quantitative angio- 
graphic study (41), it was found that this may be largely a result 
of laser catheter undersizing rather than inefficient tissue 
removal by laser ablation. However, we complied with the 
general methodology not to use laser catheters with a diameter 
larger than two-thirds of the reference diameter of the vessel 
to reduce the risk of perforation, thereby limiting lumen gain 
by laser ablation. The procedural outcome of excimer laser- 
assisted balloon angioplasty may, hence, largely be determined 
by the therapeutic effect of the "adjunctive" balloon dilation. 
The relative contribution of true debulking, that is, tissue 
removal by laser vaporization, and mere dilatory effects by 
excimer laser angioplasty in the recanalization of arterial 
obstructions remains to be determined. 
Restenosis. Although acute lumen gain was similar in both 
treatment groups, the laser-treated group exhibited signifi- 
cantly greater lumen loss during follow-up, resulting in a 
significantly smaller minimal lumen diameter at follow-up. 
Why is there more restenosis after excimer laser angioplasty 
(7,9,10,32)? Two possible explanations may exist for this 
different behavior of the treated artery during follow-up: 
1. In the achievement of a similar degree of acute lumen 
gain, excimer laser-assisted balloon angioplasty may inflict 
more damage to the vessel wall than balloon dilation alone. 
The intraluminal delivery of excimer laser pulses ha  been 
shown (38,39) to induce extensive damage to the adjacent 
arterial wall, including medial necrosis, dissection planes filled 
with red blood cells and internal elastic lamina brasion. 
Schwartz et al. (27,28) have shown a strong relation between 
the extent of vessel wall injury during intervention and the 
degree of subsequent eointimal thickening in a swine model. 
Greater damage (injury) to the treated vessel segment would 
provoke a proportionally greater proliferative response (re- 
pair). Excimer laser angioplasty may give rise to a strong 
reparative, inflammatory reaction that would possibly not 
occur to that extent after the comparatively esser trauma of 
balloon dilation. The more aggressive neointimal response may 
be appreciated angiographically as greater lumen loss at 
follow-up. A quantitative angiographic analysis of exeimer 
laser-assisted angioplasty of saphenous vein graft lesions sug- 
gested (42) that aggressive laser tissue debulking may adversely 
affect restenosis. 
2. Excimer laser irradiation itself may inherently provoke a 
unique response of the vessel wall that precipitates more 
extensive neointimai hyperplasia. At the cellular level, the 
ultraviolet radiation from an excimer laser may be mutagenic 
(43), promoting the proliferation and growth of smooth muscle 
cells and production of extracellular matrix. 
Linear regression analysis has shown a correlation between 
relative gain at intervention (as an index of vessel wall injury) 
and relative loss during follow-up (as an index for neointimal 
hyperplasia) after balloon angioplasty (26,44), Wiktor stent 
implantation (30), directional athereetomy (15,31) and excimer 
laser-facilitated coronary angioplasty (32). In our patients, a
statistically significant, though somewhat weak, correlation was 
found between relative gain and relative loss in both treatment 
groups. More important, however, is the observation that the 
regression line is much steeper in the laser-treated group 
(slope 0.71 vs. 0.30; p -- 0.05). Also, the loss index (late loss 
divided by acute gain) was greater in the laser-treated group 
than in the balloon angioplasty group (0.63 vs. 0.35, p = 0.10). 
These findings imply a greater eactive response of the vessel 
wall after excimer laser-assisted balloon angioplasty than fter 
conventional balloon angioplasty for any given level of lumen 
gain. These observations are in disagreement with the model 
for restenosis as proposed by Kuntz et al. (33), which describes 
a uniform behavior of the vessel wall during follow-up, inde- 
pendent of the device used for intervention. Loss index in that 
model was consistently observed at 0.47 for balloon angio- 
plasty, stenting or atherectomy. More recently, Bittl et al. (32) 
reported a loss index after excimer laser-facilitated coronary 
angioplasty of 0.58. Although of borderline statistical signifi- 
cance, the differential findings in thepresent study with respect 
to lumen renarrowing after intervention suggest that there may 
in fact be a device-specific influence on the neointimal re- 
sponse independent of lumen increase. Comparisons of late 
angiographic outcome in patients treated by coronary balloon 
angioplasty, stent implantation and directional atherectomy b  
our group have previously suggested the possibility of such a 
device-specific effect (45-47). 
Study limitations. The present study has several imita- 
tions: 
1. It is an observational study in relatively small patient 
groups using a new interventional technique under continuous 
development. Future modifications in catheter design and 
treatment protocols may improve immediate and late results. 
2. Because only successful procedures are compared, the 
present study does not give insight into the primary success 
rates of the two techniques. In observational registries, excimer 
laser angioplasty with or without adjunctive balloon dilation 
has been found to be associated with a higher primary success 
rate than balloon angioplasty alone, particularly in lesions with 
complex morphology (8-14). Consequently, selection bias 
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cannot be totally excluded. Although not statistically signifi- 
cant, there was a tendency toward treatment of somewhat 
longer lesions with the excimer laser than with balloon angio- 
plasty. Longer lesions have been found to be independently 
associated with greater lumen loss during follow-up after 
coronary balloon angioplasty (29) but not after excimer laser- 
facilitated angioplasty (32). 
3. Although the two groups are well matched for several 
angiographic variables and some patient characteristics (age, 
gender and angina class), procedure-related and other patient 
variables, such as diabetes or previous treatment at the lesion 
site, are not included in the analysis. However, in a previous 
matching study (15) it was shown that inclusion f additional 
clinical variables reduces the number of lesions that can be 
successfully matched without changing the nature of th  
angiographic findings. A prospective, randomized investigation 
is currently being completed in The Netherlands to assess the 
immediate and long-term efficacy of excimer laser and balloon 
angioplasty in the treatment of long (>10 mm) coronary 
lesions (AMRO trial) (48,49). In view of the reasonably 
accurate prediction of the angiographic outcomes of recent 
major multicenter randomized trials of two new devices with 
conventional balloon angioplasty (17-20) by previous matching 
studies such as the present one(15,16), the final outcome of 
randomized comparisons of excimer laser and balloon coro- 
nary angioplasty (34,49) may wellhave been predicted in the 
present observational study. 
Conclusions. In this study of matched coronary lesions, 
excimer laser angioplasty (with adjunctive balloon dilation in 
94% of cases) achieved a similar immediate angiographic 
result as conventional balloon angioplasty but, as a result of 
more pronounced lumen renarrowing, was associated with a 
significantly less favorable long-term angiographic outcome. 
We acknowledge Jaap Pameyer and the angiographic core laboratory, Cardialysis 
for the quantitative angiographic analyses. 
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